Hrt Financial LP Pliant Therapeutics, Inc. Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$12.85 - $19.15 $365,325 - $544,434	28,430 New	28,430 $514,000
Q1 2023 May 12, 2023	BUY	$18.73 - $36.26 $3.1 Million - $6 Million	165,512 New	165,512 $4.4 Million
Q3 2022 Nov 14, 2022	BUY	$7.67 - $24.23 $86,970 - $274,743	11,339 New	11,339 $236,000
Q1 2022 May 16, 2022	SELL	$7.01 - $14.1 $275,478 - $554,101	-39,298 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.26 $482,186 - $717,581	39,298 New	39,298 $530,000

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.